U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
"We are not hooligans, we understand the legitimacy of our demands," a coordination group member said.
Activists launched the "No to Plunder" initiative against electricity price hike on the evening of June 22 outside the presidential residence.
“No to Robbery” civic initiative and several political forces staged a rally in Yerevan to protest the rise in tariffs.
The official launch ceremony of the Farm Service Center was held with the participation of the U.S. ambassador to Armenia.
Partner news